Status:
COMPLETED
Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Carotid Atherosclerosis
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
This study will examine the effect of statin and niacin therapy on carotid plaque biomarkers
Eligibility Criteria
Inclusion
- Patient is diagnosed with carotid stenosis AND is scheduled to undergo carotid endarterectomy
- Female patients of reproductive potential must abstain from sex or use an acceptable method of birth control through out the study
Exclusion
- Patient must undergo CEA less than 4 weeks after entering study
- Patient has recent history of acute coronary syndrome
- Patient has has coronary artery bypass graft surgery within 30 days of study start
- Patient has thyroid disease that has not been treated for more than 6 weeks
- Patient has donated blood within 8 weeks of study start
- Patient has poorly controlled diabetes mellitis
- Patient has human immunodeficiency virus (HIV) or Hepatitis B or C
- Patient is taking warfarin or other anticoagulants
- Patient is taking hormone replacement therapy
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00804843
Start Date
April 1 2009
End Date
October 1 2010
Last Update
September 30 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.